{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:55:43Z","timestamp":1792061743140,"version":"4.4.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":868,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ50166"],"award-info":[{"award-number":["2022JJ50166"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chinese Medical Sciences Journal"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.24920\/004220","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T20:37:55Z","timestamp":1702586275000},"page":"286-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Influence of Gut Microbiota and its Metabolites on Progression of Metabolic Associated Fatty Liver Disease"],"prefix":"10.1016","volume":"38","author":[{"given":"Yuan-Yuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Lian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Lang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen-Xiang","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La-Mei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.24920\/004220_bib1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s10620-016-4143-0","article-title":"Global epidemiology of nonalcoholic fatty liver disease and perspectives on US minority populations","volume":"61","author":"Sherif","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.24920\/004220_bib2","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"8","key":"10.24920\/004220_bib3","doi-asserted-by":"crossref","first-page":"e1002533","DOI":"10.1371\/journal.pbio.1002533","article-title":"Revised estimates for the number of human and bacteria cells in the body","volume":"14","author":"Sender","year":"2016","journal-title":"PLoS Biol"},{"issue":"5","key":"10.24920\/004220_bib4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab"},{"issue":"9","key":"10.24920\/004220_bib5","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1136\/gutjnl-2014-306928","article-title":"Microbiota and diabetes: an evolving relationship","volume":"63","author":"Tilg","year":"2014","journal-title":"Gut"},{"issue":"11-12","key":"10.24920\/004220_bib6","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/apt.17233","article-title":"Prevalence and clinical characteristics of patients with metabolic dysfunction-associated fatty liver disease with hepatitis C virus infection-a population-based study","volume":"56","author":"Attia","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.24920\/004220_bib7","doi-asserted-by":"crossref","first-page":"154868","DOI":"10.1016\/j.metabol.2021.154868","article-title":"Diabetes and metabolic dysfunction-associated fatty liver disease","volume":"123","author":"Davis","year":"2021","journal-title":"Metabolism"},{"issue":"1","key":"10.24920\/004220_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"3","key":"10.24920\/004220_bib9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/medicina59030594","article-title":"Metabolic-dysfunction-associated fatty liver disease and gut microbiota: from fatty liver to dysmetabolic syndrome","volume":"59","author":"Abenavoli","year":"2023","journal-title":"Medicina (Kaunas)"},{"issue":"4","key":"10.24920\/004220_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1249\/MSS.0000000000001495","article-title":"Exercise alters gut microbiota composition and function in lean and obese humans","volume":"50","author":"Allen","year":"2018","journal-title":"Med Sci Sports Exerc"},{"key":"10.24920\/004220_bib11","doi-asserted-by":"crossref","first-page":"113290","DOI":"10.1016\/j.biopha.2022.113290","article-title":"Diet-gut microbiota-epigenetics in metabolic diseases: from mechanisms to therapeutics","volume":"153","author":"Li","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.24920\/004220_bib12","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1053\/j.gastro.2022.06.070","article-title":"Population-level metagenomics uncovers distinct effects of multiple medications on the human gut microbiome","volume":"163","author":"Nagata","year":"2022","journal-title":"Gastroenterology"},{"issue":"8","key":"10.24920\/004220_bib13","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.24920\/004220_bib14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cmet.2015.07.026","article-title":"Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling","volume":"22","author":"Caesar","year":"2015","journal-title":"Cell Metab"},{"issue":"3","key":"10.24920\/004220_bib15","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"issue":"13","key":"10.24920\/004220_bib16","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1021\/acs.jafc.9b00249","article-title":"Alterations of bile acids and gut microbiota in obesity induced by high fat diet in rat model","volume":"67","author":"Lin","year":"2019","journal-title":"3 Agric Food Chem"},{"issue":"1","key":"10.24920\/004220_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstrdm","year":"2016","journal-title":"Cell Metab"},{"key":"10.24920\/004220_bib18","doi-asserted-by":"crossref","first-page":"658354","DOI":"10.3389\/fimmu.2021.658354","article-title":"Impact of bacterial metabolites on gut barrier function and host immunity: a focus on bacterial metabolism and its relevance for intestinal inflammation","volume":"12","author":"Gasaly","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.24920\/004220_bib19","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"issue":"12","key":"10.24920\/004220_bib20","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.3390\/nu14122456","article-title":"How diet and physical activity modulate gut microbiota: evidence and perspectives","volume":"14","author":"Campaniello","year":"2022","journal-title":"Nutrients"},{"issue":"10","key":"10.24920\/004220_bib21","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s40279-022-01696-x","article-title":"The connection between physical exercise and gut microbiota: implications for competitive sports athletes","volume":"52","author":"Wegierska","year":"2022","journal-title":"Sports Med"},{"issue":"5","key":"10.24920\/004220_bib22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cmet.2021.03.015","article-title":"Circadian rhythms and the gut microbiome synchronize the host's metabolic response to diet","volume":"33","author":"Gutierrez Lopez","year":"2021","journal-title":"Cell Metab"},{"issue":"6","key":"10.24920\/004220_bib23","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3109\/08820139.2011.575425","article-title":"Effect of moderate exercise on IgA levels and lymphocyte count in mouse intestine","volume":"40","author":"Viloria","year":"2011","journal-title":"Immunol Invest"},{"issue":"5","key":"10.24920\/004220_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/14787210.2018.1467268","article-title":"Metagenomics, culturomics, and the human gut microbiota","volume":"16","author":"Amrane","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"10.24920\/004220_bib25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2014.09.053","article-title":"Human genetics shape the gut microbiome","volume":"159","author":"Goodrich","year":"2014","journal-title":"Cell"},{"issue":"12","key":"10.24920\/004220_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13073-014-0107-1","article-title":"Complex host genetics influence the microbiome in inflammatory bowel disease","volume":"6","author":"Knights","year":"2014","journal-title":"Genome Med"},{"issue":"2","key":"10.24920\/004220_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41588-021-00992-y","article-title":"Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project","volume":"54","author":"Lopera-Maya","year":"2022","journal-title":"Nat Genet"},{"issue":"7695","key":"10.24920\/004220_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nature25973","article-title":"Environment dominates over host genetics in shaping human gut microbiota","volume":"555","author":"Rothschild","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.24920\/004220_bib29","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/liv.14899","article-title":"Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy-proven non-alcoholic fatty liver disease","volume":"41","author":"Lang","year":"2021","journal-title":"Liver Int"},{"key":"10.24920\/004220_bib30","doi-asserted-by":"crossref","first-page":"111180","DOI":"10.1016\/j.foodres.2022.111180","article-title":"Sequentially fermented dealcoholized apple juice intervenes fatty liver induced by high-fat diets via modulation of intestinal flora and gene pathways","volume":"156","author":"Li","year":"2022","journal-title":"Food Res Int"},{"issue":"4","key":"10.24920\/004220_bib31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.24920\/004220_bib32","doi-asserted-by":"crossref","first-page":"188494","DOI":"10.1016\/j.bbcan.2020.188494","article-title":"Effect of probiotics and gut microbiota on anti-cancer drugs: mechanistic perspectives","volume":"1875","author":"Badgeley","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"11","key":"10.24920\/004220_bib33","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1136\/gutjnl-2016-312297","article-title":"Antibiotics as deep modulators of gut microbiota: between good and evil","volume":"65","author":"Ianiro","year":"2016","journal-title":"Gut"},{"issue":"2","key":"10.24920\/004220_bib34","doi-asserted-by":"crossref","first-page":"178.e1","DOI":"10.1016\/j.cmi.2015.10.003","article-title":"The influence of non-steroidal anti-inflammatory drugs on the gut microbiome","volume":"22","author":"Rogers","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.24920\/004220_bib35","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1038\/s41467-019-12873-4","article-title":"Intestinal microbiome composition and its relation to joint pain and inflammation","volume":"10","author":"Boer","year":"2019","journal-title":"Nat Commun"},{"key":"10.24920\/004220_bib36","doi-asserted-by":"crossref","first-page":"105840","DOI":"10.1016\/j.phrs.2021.105840","article-title":"The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders","volume":"172","author":"Socata","year":"2021","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.24920\/004220_bib37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","article-title":"Gut microbiota and cardiovascular disease","volume":"127","author":"Witkowski","year":"2020","journal-title":"Circ Res"},{"issue":"1","key":"10.24920\/004220_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.24920\/004220_bib39","doi-asserted-by":"crossref","first-page":"e62885","DOI":"10.1371\/journal.pone.0062885","article-title":"Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis\u2014a longitudinal study","volume":"8","author":"Wong","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.24920\/004220_bib40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.26319","article-title":"Intestinal microbiota in patients with nonalcoholic fatty liver disease","volume":"58","author":"Mouzaki","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.24920\/004220_bib41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"2","key":"10.24920\/004220_bib42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"issue":"7","key":"10.24920\/004220_bib43","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","article-title":"Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women","volume":"24","author":"Hoyles","year":"2018","journal-title":"Nat Med"},{"issue":"10","key":"10.24920\/004220_bib44","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"issue":"1","key":"10.24920\/004220_bib45","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1038\/s41467-022-34671-1","article-title":"Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism","volume":"13","author":"Lei","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"10.24920\/004220_bib46","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3945\/jn.113.185389","article-title":"Choline supplementation protects against liver damage by normalizing cholesterol metabolism in Pemt\/Ldlr knockout mice fed a high-fat diet","volume":"144","author":"Al Rajabi","year":"2014","journal-title":"J Nutr"},{"issue":"3","key":"10.24920\/004220_bib47","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.celrep.2014.12.036","article-title":"The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance","volume":"10","author":"Warner","year":"2015","journal-title":"Cell Rep"},{"issue":"1","key":"10.24920\/004220_bib48","first-page":"96","article-title":"Protein and amino acids in nonalcoholic fatty liver disease","volume":"24","author":"Trico","year":"2021","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"8","key":"10.24920\/004220_bib49","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/gutjnl-2019-318811","article-title":"Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease","volume":"69","author":"Sookoian","year":"2020","journal-title":"Gut"},{"issue":"3","key":"10.24920\/004220_bib50","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/hep.29892","article-title":"Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.24920\/004220_bib51","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"Schnabl","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.24920\/004220_bib52","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"key":"10.24920\/004220_bib53","first-page":"324","article-title":"Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome","volume":"8","author":"Liu","year":"2017","journal-title":"Front Microbiol"},{"issue":"12","key":"10.24920\/004220_bib54","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/jnci\/dji164","article-title":"Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition","volume":"97","author":"Norat","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.24920\/004220_bib55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/gutjnl-2015-309800","article-title":"Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer","volume":"66","author":"Yu","year":"2017","journal-title":"Gut"},{"key":"10.24920\/004220_bib56","doi-asserted-by":"crossref","first-page":"103290","DOI":"10.1016\/j.ebiom.2021.103290","article-title":"Conjugated secondary 12\u03b1-hydroxylated bile acids promote liver fibrogenesis","volume":"66","author":"Xie","year":"2021","journal-title":"EBioMedicine"},{"issue":"6","key":"10.24920\/004220_bib57","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J Hepatol"},{"issue":"21","key":"10.24920\/004220_bib58","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.3390\/ijms21218351","article-title":"The gut barrier, intestinal microbiota, and liver disease: molecular mechanisms and strategies to manage","volume":"21","author":"Plaza-D\u00edaz","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.24920\/004220_bib59","doi-asserted-by":"crossref","first-page":"14578","DOI":"10.1038\/s41598-022-18771-y","article-title":"Inflammatory cytokines directly disrupt the bovine intestinal epithelial barrier","volume":"12","author":"Crawford","year":"2022","journal-title":"Sci Rep"},{"key":"10.24920\/004220_bib60","doi-asserted-by":"crossref","first-page":"106507","DOI":"10.1016\/j.phrs.2022.106507","article-title":"Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease","volume":"185","author":"Khanmohammadi","year":"2022","journal-title":"Pharmacol Res"},{"issue":"21","key":"10.24920\/004220_bib61","doi-asserted-by":"crossref","first-page":"9702","DOI":"10.7150\/thno.44297","article-title":"Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder","volume":"10","author":"Hu","year":"2020","journal-title":"Theranostics"},{"issue":"3","key":"10.24920\/004220_bib62","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/hep.32642","article-title":"Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality","volume":"77","author":"van Kleef","year":"2023","journal-title":"Hepatology"},{"issue":"9","key":"10.24920\/004220_bib63","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1021\/jf502990n","article-title":"Protective effect of panax notoginseng saponins on acute ethanol-induced liver injury is associated with ameliorating hepatic lipid accumulation and reducing ethanol-mediated oxidative stress","volume":"63","author":"Ding","year":"2015","journal-title":"J Agric Food Chem"},{"issue":"5","key":"10.24920\/004220_bib64","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7150\/ijbs.11039","article-title":"The effects of insulin pre-administration in mice exposed to ethanol: alleviating hepatic oxidative injury through anti-oxidative, anti-apoptotic activities and deteriorating hepatic steatosis through SRBEP-1c activation","volume":"11","author":"Liu","year":"2015","journal-title":"Int J Biol Sci"},{"key":"10.24920\/004220_bib65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.alcohol.2019.11.004","article-title":"Repeated ethanol exposure influences key enzymes in cholesterol and lipid homeostasis via the AMPK pathway in the rat prefrontal cortex","volume":"85","author":"Xu","year":"2020","journal-title":"Alcohol"},{"issue":"1","key":"10.24920\/004220_bib66","doi-asserted-by":"crossref","first-page":"12923","DOI":"10.1038\/s41598-018-31025-0","article-title":"Ethanol and C2 ceramide activate fatty acid oxidation in human hepatoma cells","volume":"8","author":"Correnti","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"10.24920\/004220_bib67","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jcmgh.2019.10.005","article-title":"Tributyrin inhibits ethanol-induced epigenetic repression of CPT-1A and attenuates hepatic steatosis and injury","volume":"9","author":"Donde","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"10.24920\/004220_bib68","doi-asserted-by":"crossref","first-page":"100387","DOI":"10.1016\/j.jhepr.2021.100387","article-title":"Bile acids contribute to the development of non-alcoholic steatohepatitis in mice","volume":"4","author":"Gillard","year":"2022","journal-title":"JHEP Rep"},{"issue":"6556","key":"10.24920\/004220_bib69","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1126\/science.aba3683","article-title":"High-fat diet-induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide","volume":"373","author":"Yoo","year":"2021","journal-title":"Science"},{"issue":"11","key":"10.24920\/004220_bib70","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1002\/hep4.2066","article-title":"Population-based meta-analysis and gene-set enrichment identifies FXR\/RXR pathway as common to fatty liver disease and serum lipids","volume":"6","author":"Handelman","year":"2022","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.24920\/004220_bib71","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11306-019-1494-5","article-title":"Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathways","volume":"15","author":"Kim","year":"2019","journal-title":"Metabolomics"},{"key":"10.24920\/004220_bib72","doi-asserted-by":"crossref","first-page":"6645970","DOI":"10.1155\/2021\/6645970","article-title":"Gut dysbiosis and abnormal bile acid metabolism in colitis-associated cancer","volume":"2021","author":"Liu","year":"2021","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"10.24920\/004220_bib73","doi-asserted-by":"crossref","first-page":"100230","DOI":"10.1016\/j.jhepr.2021.100230","article-title":"Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis","volume":"3","author":"Spatz","year":"2021","journal-title":"JHEP Rep"},{"key":"10.24920\/004220_bib74","doi-asserted-by":"crossref","first-page":"164307","DOI":"10.1016\/j.scitotenv.2023.164307","article-title":"Bisphenol A induced hepatic steatosis by disturbing bile acid metabolism and FXR\/TGR5 signaling pathways via remodeling the gut microbiota in CD-I mice","volume":"889","author":"Hong","year":"2023","journal-title":"Sci Total Environ"},{"issue":"4","key":"10.24920\/004220_bib75","doi-asserted-by":"crossref","first-page":"101742","DOI":"10.1016\/j.psj.2022.101742","article-title":"Dietary fibers with different viscosity regulate lipid metabolism via ampk pathway: roles of gut microbiota and short-chain fatty acid","volume":"101","author":"Li","year":"2022","journal-title":"Poult Sci"},{"issue":"1","key":"10.24920\/004220_bib76","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12865-022-00495-3","article-title":"Three important short-chain fatty acids (SCFAs) attenuate the inflammatory response induced by 5-FU and maintain the integrity of intestinal mucosal tight junction","volume":"23","author":"Yue","year":"2022","journal-title":"BMC Immunol"},{"issue":"1","key":"10.24920\/004220_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1842990","article-title":"Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity","volume":"12","author":"Zhang","year":"2020","journal-title":"Gut Microbes"},{"issue":"7","key":"10.24920\/004220_bib78","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3390\/metabo13070859","article-title":"Differences in fecal short-chain fatty acids between alcoholic fatty liver-induced cirrhosis and non-alcoholic (metabolic-associated) fatty liver-induced cirrhosis","volume":"13","author":"Cao","year":"2023","journal-title":"Metabolites"},{"issue":"6","key":"10.24920\/004220_bib79","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/liv.14428","article-title":"Targeting ferroptosis alleviates methionine-choline deficient (MCD)-diet induced NASH by suppressing liver lipotoxicity","volume":"40","author":"Li","year":"2020","journal-title":"Liver Int"},{"key":"10.24920\/004220_bib80","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.trsl.2020.07.008","article-title":"The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet","volume":"227","author":"Somm","year":"2021","journal-title":"Transl Res"},{"issue":"1","key":"10.24920\/004220_bib81","first-page":"96","article-title":"Protein and amino acids in nonalcoholic fatty liver disease","volume":"24","author":"Tric6","year":"2021","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"9","key":"10.24920\/004220_bib82","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2337\/db18-0927","article-title":"Targeting BCAA catabolism to treat obesity-associated insulin resistance","volume":"68","author":"Zhou","year":"2019","journal-title":"Diabetes"},{"issue":"7612","key":"10.24920\/004220_bib83","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature18646","article-title":"Human gut microbes impact host serum metabolome and insulin sensitivity","volume":"535","author":"Pedersen","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.24920\/004220_bib84","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/hepr.13346","article-title":"Branched chain amino acids are associated with the heterogeneity of the area of lipid droplets in hepatocytes of patients with non-alcoholic fatty liver disease","volume":"49","author":"Kakazu","year":"2019","journal-title":"Hepatol Res"},{"issue":"4","key":"10.24920\/004220_bib85","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-Gomez","year":"2017","journal-title":"J Hepatol"},{"issue":"6","key":"10.24920\/004220_bib86","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1053\/j.gastro.2018.08.022","article-title":"FXR-dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid","volume":"155","author":"Friedman","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.24920\/004220_bib87","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"issue":"7","key":"10.24920\/004220_bib88","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"10.24920\/004220_bib89","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41577-019-0144-5","article-title":"Mining the microbiota for microbial and metabolite-based immunotherapies","volume":"19","author":"Skelly","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"9972","key":"10.24920\/004220_bib90","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.24920\/004220_bib91","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12915-017-0462-7","article-title":"Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice","volume":"15","author":"Zheng","year":"2017","journal-title":"BMC Biol"},{"issue":"4","key":"10.24920\/004220_bib92","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1124\/mol.110.064501","article-title":"Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist","volume":"78","author":"Rizzo","year":"2010","journal-title":"Mol Pharmacol"},{"issue":"13","key":"10.24920\/004220_bib93","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1074\/jbc.M115.699504","article-title":"Activation of transmembrane bile acid receptor TGR5 modulates pancreatic islet a cells to promote glucose homeostasis","volume":"291","author":"Kumar","year":"2016","journal-title":"J Biol Chem"},{"issue":"2","key":"10.24920\/004220_bib94","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3748\/wjg.v24.i2.195","article-title":"INT-767 improves histopathological features in a diet-induced ob\/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis","volume":"24","author":"Roth","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.24920\/004220_bib95","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1530\/JOE-20-0018","article-title":"SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD","volume":"245","author":"Deng","year":"2020","journal-title":"J Endocrinol"},{"issue":"4","key":"10.24920\/004220_bib96","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s10787-018-0479-8","article-title":"Probiotic mixture of Lactobacillus and Bifidobacterium alleviates systemic adiposity and inflammation in non-alcoholic fatty liver disease rats through Gpr109a and the commensal metabolite butyrate","volume":"26","author":"Liang","year":"2018","journal-title":"Inflammopharmacology"},{"issue":"9","key":"10.24920\/004220_bib97","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","author":"den Besten","year":"2013","journal-title":"J Lipid Res"},{"issue":"3","key":"10.24920\/004220_bib98","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MPG.0000000000001422","article-title":"Effects of probiotics on nonalcoholic fatty liver disease in obese children and adolescents","volume":"64","author":"Famouri","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.24920\/004220_bib99","doi-asserted-by":"crossref","first-page":"418","DOI":"10.23736\/S0026-4806.18.05845-7","article-title":"Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study","volume":"109","author":"Kobyliak","year":"2018","journal-title":"Minerva Med"},{"issue":"1","key":"10.24920\/004220_bib100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1665-2681(19)31401-2","article-title":"Probiotics: a possible role in treatment of adult and pediatric non alcoholic fatty liver disease","volume":"12","author":"Vajro","year":"2013","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.24920\/004220_bib101","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.numecd.2012.10.006","article-title":"Probiotics in the treatment of non alcoholic fatty liver disease: further evidence in obese children","volume":"23","author":"Vajro","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"10.24920\/004220_bib102","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/1756283X15622600","article-title":"Fecal microbiota transplant for Clostridium difficile infection in older adults","volume":"9","author":"Tauxe","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"issue":"11","key":"10.24920\/004220_bib103","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.17219\/acem\/140506","article-title":"A novel therapeutic approach to NASH: both polyethylene glycol 3350 and lactulose reduce hepatic inflammation in C57BL\/6J mice","volume":"30","author":"Gokcen","year":"2021","journal-title":"Adv Clin Exp Med"},{"issue":"1","key":"10.24920\/004220_bib104","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41598-017-01751-y","article-title":"Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"10.24920\/004220_bib105","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/apt.14275","article-title":"Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy","volume":"46","author":"Kang","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.24920\/004220_bib106","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/liv.13200","article-title":"Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy","volume":"37","author":"Moratalla","year":"2017","journal-title":"Liver Int"},{"issue":"2","key":"10.24920\/004220_bib107","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11011-012-9303-0","article-title":"A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy","volume":"27","author":"Bajaj","year":"2012","journal-title":"Metab Brain Dis"},{"issue":"45","key":"10.24920\/004220_bib108","doi-asserted-by":"crossref","first-page":"16831","DOI":"10.3748\/wjg.v20.i45.16831","article-title":"Alimentary regimen in non-alcoholic fatty liver disease: mediterranean diet","volume":"20","author":"Abenavoli","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.24920\/004220_bib109","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.3390\/nu11092062","article-title":"Indole-3-acetic acid alleviates nonalcoholic fatty liver disease in mice via attenuation of hepatic lipogenesis, and oxidative and inflammatory stress","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"issue":"5","key":"10.24920\/004220_bib110","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","article-title":"Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis","volume":"58","author":"Reiberger","year":"2013","journal-title":"J Hepatol"}],"container-title":["Chinese Medical Sciences Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1001929424000063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1001929424000063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/cmsj.cams.cn\/previewFile?fileName=Application%20of%20Tranexamic%20Acid%20in%20Shoulder%20Arthroscopic%20Surgery%3A%20A%20Randomised%20Controlled%20Trial&id=62078847&type=pdf&lang=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:35:55Z","timestamp":1792060555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1001929424000063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1001929424000063"],"URL":"https:\/\/doi.org\/10.24920\/004220","relation":{},"ISSN":["1001-9294"],"issn-type":[{"value":"1001-9294","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of Gut Microbiota and its Metabolites on Progression of Metabolic Associated Fatty Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Chinese Medical Sciences Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.24920\/004220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 Chinese Academy Medical Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}